Curis
CRIS
#11076
Rank
NZ$8.28 M
Marketcap
NZ$1.24
Share price
-23.04%
Change (1 day)
-46.72%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -NZ$15.06 Million

According to Curis's latest financial reports the company's current earnings are NZ$4.31 Million. In 2025 the company made an earning of -NZ$9.6 Million, an increase over its 2024 earnings that were of -NZ$76.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$15.06 Million56.84%
2025 -NZ$9.6 Million-87.38%
2024 -NZ$76.06 Million-5.77%
2023 -NZ$80.72 Million-13.1%
2022 -NZ$92.89 Million27.52%
2021 -NZ$72.84 Million65.09%
2020 -NZ$44.12 Million-9.1%
2019 -NZ$48.54 Million-4.73%
2018 -NZ$50.95 Million-41.95%
2017 -NZ$87.76 Million-14.37%
2016 -NZ$0.11 Billion3.55%
2015 -NZ$98.97 Million271.52%
2014 -NZ$26.64 Million76.64%
2013 -NZ$15.08 Million
2011 -NZ$12.81 Million27.76%
2010 -NZ$10.03 Million-43.87%
2009 -NZ$17.87 Million-23.44%
2008 -NZ$23.33 Million56.66%
2007 -NZ$14.9 Million-16.71%
2006 -NZ$17.88 Million-36.92%
2005 -NZ$28.35 Million156.25%
2004 -NZ$11.07 Million-37.24%
2003 -NZ$17.63 Million-93.34%
2002 -NZ$0.27 Billion86.79%
2001 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.28 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.14 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$1.89 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.58 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$39.58 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA